Group 1 - The core viewpoint of the news is that Xinhongcheng is actively expanding its business in various sectors, including bio-fermentation, new materials, and flavor and fragrance, with a focus on innovation and overseas expansion [1] - Xinhongcheng's bio-fermentation products include Vitamin C and Coenzyme Q10, indicating a strong product portfolio in the health sector [1] - The new materials segment shows significant growth potential, with strong synergy with the main business [1] - The flavor and fragrance business is projected to achieve revenue of 3.916 billion yuan in 2024, representing a year-on-year growth of 19.62% [1] - The company is preparing for trial production of its liquid methionine project and has received multiple approvals for its Tianjin nylon new materials project [1] - Xinhongcheng emphasizes innovation-driven strategies to enhance its competitiveness in the fine chemical industry [1] - The company plans to implement two cash dividends in 2025 and introduce a buyback plan to boost market confidence [1] Group 2 - Shanghai Kuanyuan Asset Management Co., Ltd. was established in May 2014 with a registered capital of 10 million yuan, focusing on asset management, industrial investment, and financial consulting [2] - The core research team of Kuanyuan Asset has over 10 years of successful investment experience in the secondary market, consistently ranking among the top in the industry [2] - Kuanyuan Asset adheres to a value investment philosophy, aiming to identify certain growth opportunities and share in the growth of listed companies [2]
【私募调研记录】宽远资产调研新 和 成